source
- FDA approves nivolumab plus AVD for untreated advanced-stage Hodgkin lymphomaDr. Alex Herrera, a professor and chief of lymphoma at City of Hope, highlighted the recent FDA clearance of the combination of nivolumab with the chemotherapy regimen AVD for patients with newly d…
- Novo Nordisk lifts 2026 guidance as Wegovy sales surge in Q1Novo Nordisk reported its first‑quarter results, noting that sales and operating profit are expected to decline less than previously forecast. The company said adjusted sales fell between 4% and 1…